Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

45.860
+2.1204.85%
Volume:6.64M
Turnover:296.30M
Market Cap:26.69B
PE:-10.24
High:45.880
Open:43.500
Low:43.000
Close:43.740
52wk High:80.900
52wk Low:29.980
Shares:582.00M
HK Float Shares:582.00M
Volume Ratio:0.71
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:6.22
PE(LYR):-10.24
PS:25.20

Loading ...

Insilico Shares Surge Nearly 14% on Inclusion in Key China Index Series, Following Multiple Major Index Additions

Stock News
·
Jun 18

Insilico Medicine's Stock Surges Over 6% Against Market Trend as Rentosertib Phase 3 Trial Meeting Commences

Stock News
·
Jun 18

Movement Alert|Insilico Medicine Rises 5.05% in Regular Trading, ISM8969 First-in-Human Dosing Milestone Catalyst Extends with Sector Tailwind

Market Focus
·
Jun 18

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven Nlrp3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration With Hygtia Therapeutics

THOMSON REUTERS
·
Jun 17

InSilico Medicine Completes First Human Dosing of Parkinson's Disease Drug in Phase 1 Trial

MT Newswires Live
·
Jun 17

INSILICO Shares Surge Over 6% in Morning Session Following First Patient Dosing Milestone for NLRP3 Inhibitor

Stock News
·
Jun 17

Movement Alert|Insilico Medicine Rises 5.17% in Regular Trading, ISM8969 Achieves First Clinical Milestone with First-in-Human Dosing

Market Focus
·
Jun 17

Key Hong Kong Market Announcements: Six Firms Launch IPOs, Yum China to Acquire Pizza Hut China for US$1.2 Billion

Stock News
·
Jun 17

INSILICO and Hengtai Biotech Achieve First Clinical Milestone for Jointly Developed ISM8969, Dosing Initial Patient in Phase I Study

Stock News
·
Jun 17

Insilico Medicine completes first patient dosing in Phase 1 trial of NLRP3 inhibitor ISM8969

Reuters
·
Jun 17

Movement Alert|Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound

Market Focus
·
Jun 16

BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series

Reuters
·
Jun 15

Movement Alert|Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment

Market Focus
·
Jun 15

INSILICO Added to Key China Securities Index Series

Stock News
·
Jun 15

Movement Alert|Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness

Market Focus
·
Jun 11

Movement Alert|Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price

Market Focus
·
Jun 10

Movement Alert|Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness

Market Focus
·
Jun 09

Movement Alert|Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness

Market Focus
·
Jun 08

Insilico Medicine to Join FTSE Global Equity Index Series

MT Newswires Live
·
Jun 08

INSILICO to be Added to FTSE Global Equity Index Series

Stock News
·
Jun 08